KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Other Operating Expenses (2019 - 2025)

Aurinia Pharmaceuticals (AUPH) has disclosed Other Operating Expenses for 7 consecutive years, with $5.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Operating Expenses rose 12.61% year-over-year to $5.1 million, compared with a TTM value of -$9.5 million through Dec 2025, down 319.23%, and an annual FY2025 reading of -$9.5 million, down 319.23% over the prior year.
  • Other Operating Expenses was $5.1 million for Q4 2025 at Aurinia Pharmaceuticals, up from -$929000.0 in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $5.1 million in Q4 2025 and bottomed at -$9.2 million in Q2 2025.
  • Average Other Operating Expenses over 5 years is -$630650.0, with a median of $115000.0 recorded in 2021.
  • The sharpest move saw Other Operating Expenses soared 1522.41% in 2024, then crashed 3288.28% in 2025.
  • Year by year, Other Operating Expenses stood at $285000.0 in 2021, then surged by 661.4% to $2.2 million in 2022, then crashed by 518.16% to -$9.1 million in 2023, then skyrocketed by 149.66% to $4.5 million in 2024, then rose by 12.61% to $5.1 million in 2025.
  • Business Quant data shows Other Operating Expenses for AUPH at $5.1 million in Q4 2025, -$929000.0 in Q3 2025, and -$9.2 million in Q2 2025.